AU Stock MarketDetailed Quotes

ALA Arovella Therapeutics Ltd

Watchlist
  • 0.117
  • +0.002+1.74%
20min DelayTrading May 29 11:54 AET
122.87MMarket Cap-8357P/E (Static)

Arovella Therapeutics Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Arovella Therapeutics Ltd Earnings Date

Currency: AUD

Period

H1 FY2024 Earnings

--

Revenue(YoY)

8.50K

-97.76%
EPS(YoY)

-<0.01

+24.14%
Analyst Rating

No Data

Arovella Therapeutics Ltd Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: AUD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2023/FY405.900K / 379.590K--
--2022/FY295.810K / 1.335M--
--2021/FY257.350K / 485.000K--
--2020/FY532.690K / 740.000K--
DatePeriodRevenue/EstimateEarnings Call
--2023/FY405.900K / 379.590K--
--2022/FY295.810K / 1.335M--
--2021/FY257.350K / 485.000K--
--2020/FY532.690K / 740.000K--

Arovella Therapeutics Ltd Earnings Reports

  • Arovella Therapeutics Ltd: Appendix 4D and Half Year Report

    Feb 27 20:43 ET

  • Arovella Therapeutics Ltd: Appendix 4E and Annual Report

    Aug 30, 2023 20:16 ET

  • Arovella Therapeutics Ltd: Appendix 4D and Half Year Report

    Feb 22, 2023 17:41 ET

  • Arovella Therapeutics Ltd: Annual Report to shareholders

    Sep 28, 2022 20:03 ET

    • Read more

    Analysis

    Analyst Rating

    No Data

    Price Target

    No Data

    Heat List
    AU
    Overall
    Symbol
    Latest Price
    %Chg